Grufity logo
Grufity logo
ALVR

ALVR - AlloVir, Inc. Stock Price, Fair Value and News

$3.34-0.24 (-6.70%)
Market Closed as of 28 Jul 2026, 04:00 pm ET

Price Targets

ALVR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ALVR Price Action

Last 7 days

-14.8%

Last 30 days

-15.2%

Last 90 days

-38.9%

Trailing 12 Months

31.3%

ALVR RSI Chart

ALVR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

ALVR Valuation

Market Cap

79.5M

Price/Earnings (Trailing)

-1.8

EV/EBITDA

-1.46

Price/Free Cashflow

-1.87

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

ALVR Fundamentals

ALVR Earnings

Earnings (TTM)

-44.1M

Earnings Growth (Yr)

-6.47%

Earnings Growth (Qtr)

-8.58%

ALVR Profitability

Return on Equity

-64.32%

Return on Assets

-40.16%

Free Cashflow Yield

-53.53%

ALVR Investor Care

Shares Dilution (1Y)

487.01%

Diluted EPS (TTM)

-1.47

Revenue & Growth

How AlloVir, Inc. generates revenue and covers its expenses, based on the latest reported earnings.

About AlloVir, Inc.

ALVR
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6, and JC virus. Its preclinical and clinical development product candidates include ALVR106 for the respiratory syncytial virus, influenza, parainfluenza virus, and human metapneumovirus; ALVR109 to treat SARS-CoV-2 and COVID-19; ALVR107 for treating hepatitis B; and ALVR108. The company was formerly known as ViraCyte, Inc. and changed its name to Allovir, Inc. in May 2019. Allovir, Inc. was incorporated in 2013 and is based in Waltham, Massachusetts.
 CEO
 WEBSITEallovir.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES113

AlloVir, Inc. Frequently Asked Questions

ALVR is the stock ticker symbol of AlloVir, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Tue Jul 28 2026, market cap of AlloVir, Inc. is 79.47 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.